Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 22768167)

1.

A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.

Rogers MS, Cryan LM, Habeshian KA, Bazinet L, Caldwell TP, Ackroyd PC, Christensen KA.

PLoS One. 2012;7(6):e39911. doi: 10.1371/journal.pone.0039911. Epub 2012 Jun 29.

2.

Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.

Cryan LM, Habeshian KA, Caldwell TP, Morris MT, Ackroyd PC, Christensen KA, Rogers MS.

J Biomol Screen. 2013 Jul;18(6):714-25. doi: 10.1177/1087057113478655. Epub 2013 Mar 11.

3.

Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.

Chen KH, Liu S, Bankston LA, Liddington RC, Leppla SH.

J Biol Chem. 2007 Mar 30;282(13):9834-45. Epub 2007 Jan 24.

4.

Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.

Scobie HM, Rainey GJ, Bradley KA, Young JA.

Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5170-4. Epub 2003 Apr 16.

5.

The receptors that mediate the direct lethality of anthrax toxin.

Liu S, Zhang Y, Hoover B, Leppla SH.

Toxins (Basel). 2012 Dec 27;5(1):1-8. doi: 10.3390/toxins5010001.

6.

The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.

Li G, Qu Y, Cai C, Kong Y, Liu S, Zhang J, Zhao J, Fu L, Xu J, Chen W.

Biochem Biophys Res Commun. 2009 Aug 7;385(4):591-5. doi: 10.1016/j.bbrc.2009.05.114. Epub 2009 May 30.

PMID:
19486894
7.

Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.

Liu S, Crown D, Miller-Randolph S, Moayeri M, Wang H, Hu H, Morley T, Leppla SH.

Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12424-9. doi: 10.1073/pnas.0905409106. Epub 2009 Jul 15.

8.

The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor.

Dawson RM.

J Pharmacol Toxicol Methods. 2009 Jan-Feb;59(1):50-5. doi: 10.1016/j.vascn.2008.10.005. Epub 2008 Nov 11.

PMID:
19049885
9.

Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.

Martchenko M, Jeong SY, Cohen SN.

Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15583-8. doi: 10.1073/pnas.1010145107. Epub 2010 Aug 16.

10.

Characterization of the interaction between anthrax toxin and its cellular receptors.

Liu S, Leung HJ, Leppla SH.

Cell Microbiol. 2007 Apr;9(4):977-87.

11.

The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.

Fu S, Tong X, Cai C, Zhao Y, Wu Y, Li Y, Xu J, Zhang XC, Xu L, Chen W, Rao Z.

PLoS One. 2010 Jun 18;5(6):e11203. doi: 10.1371/journal.pone.0011203.

12.

Receptor-specific requirements for anthrax toxin delivery into cells.

Rainey GJ, Wigelsworth DJ, Ryan PL, Scobie HM, Collier RJ, Young JA.

Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13278-83. Epub 2005 Sep 1.

13.

Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.

Cai C, Che J, Xu L, Guo Q, Kong Y, Fu L, Xu J, Cheng Y, Chen W.

PLoS One. 2011;6(6):e20646. doi: 10.1371/journal.pone.0020646. Epub 2011 Jun 2.

14.

Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.

Wigelsworth DJ, Krantz BA, Christensen KA, Lacy DB, Juris SJ, Collier RJ.

J Biol Chem. 2004 May 28;279(22):23349-56. Epub 2004 Mar 24.

15.

Interactions between anthrax toxin receptors and protective antigen.

Scobie HM, Young JA.

Curr Opin Microbiol. 2005 Feb;8(1):106-12. Review.

PMID:
15694864
16.

Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.

Rogers MS, Christensen KA, Birsner AE, Short SM, Wigelsworth DJ, Collier RJ, D'Amato RJ.

Cancer Res. 2007 Oct 15;67(20):9980-5.

17.

Crystal structure of a complex between anthrax toxin and its host cell receptor.

Santelli E, Bankston LA, Leppla SH, Liddington RC.

Nature. 2004 Aug 19;430(7002):905-8. Epub 2004 Jul 4.

18.

pH effects on binding between the anthrax protective antigen and the host cellular receptor CMG2.

Rajapaksha M, Lovell S, Janowiak BE, Andra KK, Battaile KP, Bann JG.

Protein Sci. 2012 Oct;21(10):1467-80. doi: 10.1002/pro.2136. Epub 2012 Aug 22.

19.

Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.

Hu H, Leppla SH.

PLoS One. 2009 Nov 23;4(11):e7946. doi: 10.1371/journal.pone.0007946.

20.

A soluble receptor decoy protects rats against anthrax lethal toxin challenge.

Scobie HM, Thomas D, Marlett JM, Destito G, Wigelsworth DJ, Collier RJ, Young JA, Manchester M.

J Infect Dis. 2005 Sep 15;192(6):1047-51. Epub 2005 Aug 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk